Patents by Inventor Erin D. Milligan

Erin D. Milligan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10299707
    Abstract: The invention provides a quantum dot (QD) modified optical fiber-based biosensor which characterizes matrix metalloproteinase (MMP) enzyme activity at pain signaling sites in the central nervous system (CNS) in vivo. Related systems and peptide biomarker screening methods are also provided.
    Type: Grant
    Filed: April 18, 2017
    Date of Patent: May 28, 2019
    Assignee: STC.UNM
    Inventors: John B. Plumley, Erin D. Milligan, Marek Osinski
  • Publication number: 20170296108
    Abstract: The invention provides a quantum dot (QD) modified optical fiber-based biosensor which characterizes matrix metalloproteinase (MMP) enzyme activity at pain signaling sites in the central nervous system (CNS) in vivo. Related systems and peptide biomarker screening methods are also provided.
    Type: Application
    Filed: April 18, 2017
    Publication date: October 19, 2017
    Inventors: John B. Plumley, Erin D. Milligan, Marek Osinski
  • Patent number: 9655553
    Abstract: The invention provides a quantum dot (QD) modified optical fiber-based biosensor which characterizes matrix metalloproteinase (MMP) enzyme activity at pain signaling sites in the central nervous system (CNS) in vivo. Related systems and peptide biomarker screening methods are also provided.
    Type: Grant
    Filed: September 10, 2015
    Date of Patent: May 23, 2017
    Assignee: STC.UNM
    Inventors: John B. Plumley, Erin D. Milligan, Marek Osinski
  • Publication number: 20160029930
    Abstract: The invention provides a quantum dot (QD) modified optical fiber-based biosensor which characterizes matrix metalloproteinase (MMP) enzyme activity at pain signaling sites in the central nervous system (CNS) in vivo. Related systems and peptide biomarker screening methods are also provided.
    Type: Application
    Filed: September 10, 2015
    Publication date: February 4, 2016
    Inventors: JOHN B. PLUMLEY, ERIN D. MILLIGAN, MAREK OSINSKI
  • Patent number: 9155497
    Abstract: The invention provides a quantum dot (QD) modified optical fiber-based biosensor which characterizes matrix metalloproteinase (MMP) enzyme activity at pain signaling sites in the central nervous system (CNS) in vivo. Related systems and peptide biomarker screening methods are also provided.
    Type: Grant
    Filed: June 4, 2012
    Date of Patent: October 13, 2015
    Assignee: STC.UNM
    Inventors: John B. Plumley, Erin D. Milligan, Marek Osinski